<DOC>
	<DOC>NCT01138319</DOC>
	<brief_summary>RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is studying biomarkers in patients with acute myeloid leukemia.</brief_summary>
	<brief_title>Biomarkers in Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES: - To determine whether clonally expanded somatic mitochondrial DNA mutations are associated with acute myeloid leukemia. OUTLINE: Genomic DNA from blood samples obtained at diagnosis, remission, and relapse are analyzed for mitochondrial DNA mutations via PCR.</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia, Myeloid</mesh_term>
	<mesh_term>Leukemia, Myeloid, Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS: Diagnosis of acute myeloid leukemia Available blood samples from diagnosis, remission, and relapse PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: Not specified</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>adult acute myeloid leukemia</keyword>
	<keyword>childhood acute myeloid leukemia/other myeloid malignancies</keyword>
</DOC>